Soluble interleukin‐2 receptor (IL‐2R) was elevated at 1120 U/mL, and thus posttransplant lymphoproliferative disorder (PTLD) was suspected. The gene discussed is IL2RA; the disease is post-transplant lymphoproliferative disease.